{
    "nct_id": "NCT04449926",
    "official_title": "BCG and Plasma Amyloid in Non-Demented Adults",
    "inclusion_criteria": "* BCG naive\n* Ability to read, understand and sign consent form\nHealthy volunteers allowed\nMust have minimum age of 50 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* Known allergy to (components of) the BCG vaccine or serious adverse events to prior vaccine administration\n* Known active or latent Mycobacterium tuberculosis or with another mycobacterial species. A history of - or a suspicion of M. tuberculosis infection.\n* Fever (>38 C) within the past 24 hours.\n* Suspicion of active viral or bacterial infection.\n* Vaccination in the past 4 weeks or expected vaccination during the study period, independent of the type of vaccination.\n* Severely immunocompromised subjects. This exclusion category comprises: a) subjects with known infection by the human immunodeficiency virus (HIV-1); b) neutropenic subjects with less than 500 neutrophils/mm3; c) subjects with solid organ transplantation; d) subjects with bone marrow transplantation; e) subjects under chemotherapy; f) subjects with primary immunodeficiency; g) severe lymphopenia with less than 400 lymphocytes/mm3; h) treatment with any anti-cytokine therapies. i) treatment with oral or intravenous steroids defined as daily doses of 10mg prednisone or equivalent for longer than 3 months, or probable use of oral or intravenous steroids in the following four weeks.\n* Active solid or non-solid malignancy or lymphoma within the prior two years.",
    "miscellaneous_criteria": ""
}